drugset

Drugs / Sulfur Colloid

Follow last change Mar 2019 re-read 2 minutes ago

Sulfur Colloid

Diagnostic / imaging agent

Investigated by: Navidea Biopharmaceuticals

Trials 1 · a red edge is where a trial was stopped

today NCT03332940 · Ph 1

201820192020202120222023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1	NCT03332940	Dec 2017 → Mar 2019	metabolic dysfunction-associated steatohepatitis	Navidea Biopharmaceuticals	Terminated	No outcome recorded

Also used as a comparator or background therapy in 1 trial

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 4	NCT02287675 Comparator	Jan 2015 → Jan 2017	breast cancer	Kettering Health Network	Completed	No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

Field	Value	Cited text
Known as	Sulfur colloid	ClinicalTrials.gov intervention name — accepted as the source's own label NCT03332940 ↗ 1 NCT02287675 ↗
Modality	Diagnostic / imaging agent	“Technetium Tc 99m Sulfur Colloid Injection is a radioactive diagnostic agent” NCT02287675 ↗
Route	Intravenous	“All subjects will receive a single IV injection of unfiltered sulfur colloid radiolabeled with 8 mCi Tc99m on study day 0.” NCT03332940 ↗